Image

Informational Needs of Caregivers of Patients With Neuromotor Disease in Rehabilitation Hospitalization: Validation Study of the QBI-R/V

Informational Needs of Caregivers of Patients With Neuromotor Disease in Rehabilitation Hospitalization: Validation Study of the QBI-R/V

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

Background and rationale. Although the literature suggests that caregivers have different needs at various stages of the patient's illness, to date, most studies have focused only on the needs of caregivers of patients with specific diseases or during specific periods of the illness trajectory, and have not explored changes in caregivers' needs throughout the entire neuromotor recovery process, from admission to discharge in rehabilitation wards. In a patient-centered care perspective, it is important not only to explore the informal experiences of patients and caregivers regarding outcomes and consequences of the transition from hospital to home, but also their perspectives on interventions that would support them in self-management. In this context, this study represents the next phase of a qualitative study that identified the underlying dimensions of caregivers' informational needs, essential for constructing a measurement tool that allows both qualitative and quantitative assessment of these needs. The tool would make it possible to identify, upon patient admission to rehabilitation, the essential informational needs in order to address them during hospitalization. The same items would also serve to assess the response obtained, in terms of healthcare service quality, before discharge.

Study design. Experimental with low level of intervention. Objectives. The study aims to validate a questionnaire specifically developed to detect and assess the informational needs of caregivers of neurological patients during rehabilitation hospitalization (post-acute phase).

Endpoint. Creation of a reliable and valid tool for detecting the informational needs of caregivers of neurological patients during rehabilitation hospitalization.

Description

\| Sample Size \| The quality of validation studies requires the enrollment of about 4-10 patients per questionnaire item, with a minimum of 100 subjects to ensure the stability of the variance-covariance matrix. Based on this, for our study, administration to about 300 caregivers (about 25 subjects for each of the 13 participating centers) is considered adequate, assuming a data loss and/or compilation error rate of about 15%. Thus, the final sample available for analysis is about 255 subjects for the detection of needs and the study of the questionnaire's reliability and validity. \| \| Study Duration \| 3 years \| \| Study Phases \| 1) Recruitment of family members of patients hospitalized in the Neurorehabilitation Units of the participating ICS Maugeri SPA SB Institutes. (Patients with neurological diseases, recruited within 10 days from the start of hospitalization. Recruitment will take place directly in the wards, through verbal request and after explaining the purposes, halfway through the hospitalization period.) 2) Upon patient admission to the ward and in any case within the first 10 days of admission, administration of the Informational Needs Detection Questionnaire (QBI-R). 3) At patient discharge (within 7 days from the discharge date), the Informational Needs Assessment Questionnaire (QBI-V) will be provided to assess the degree of satisfaction with which informational needs have been met. \| \| Statistical Methods \| A descriptive analysis of the data collected through the questionnaires will be performed, as well as a validation study of the questionnaire. The measures derived from the questionnaires will be summarized with the mean and standard deviation or, where more appropriate, by the median and interquartile range. The factorial structure of the questionnaire will be explored, and internal consistency will be assessed by calculating item-total correlations and Cronbach's alpha coefficient. Test-retest reliability will be tested on a reduced sample of caregivers (50 subjects) evaluated at T0 and T1 using Spearman's non-parametric correlation coefficients. Furthermore, the reproducibility of the total and scale scores will be tested using intraclass correlation coefficients (ICC). Concurrent validity of the scale will also be assessed by comparison with the CNA for the QBI-R part and with the SAT-16 for the QBI-V. Finally, FSQ scores will be correlated with measures of anxiety, depression, and caregiver burden. Statistical analyses will be conducted using the Stata 11 statistical package (STATA Corp. LLC).

Eligibility

Inclusion Criteria:

  1. Male and female subjects of Italian nationality over 18 years of age;
  2. Being a caregiver/family member of a patient with a neuromotor disease;
  3. Signing the Informed Consent and agreeing to participate in all study procedures.

Exclusion Criteria:

  1. Caregivers over 80 years of age;
  2. History of cognitive/psychiatric deficits that may compromise the ability to provide help and/or understand the administered questionnaires.

Study details
    Neuro-Degenerative Diseases
    Care Givers
    Ictus
    Brain Injury
    Spinal Cord Injury

NCT07903298

Istituti Clinici Scientifici Maugeri SpA

31 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.